Search research articles
Contact Us
Filters
Showing results (81-90 of 260) with videos related to
Page
of 26
Sort By:
The American Journal of Gastroenterology
|
May 17, 2002
Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection
Henry Lik-Yuen Chan, Steven Woon-Choi Tsang, Nancy Wai-Yee Leung, et al.
Journal of Cellular Biochemistry
|
October 21, 2005
Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis
Wai-Yip Lam, Kam-Tong Leung, Patrick Tik-Wan Law, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
September 24, 2004
Effect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of LI90, a human hepatic stellate cell line
Alex Yui Hui, Alfred Sze-Lok Cheng, Henry Lik-Yuen Chan, et al.
Journal of Gastroenterology and Hepatology
|
February 8, 2020
Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B
Terry Cheuk-Fung Yip, Hye Won Lee, Vincent Wai-Sun Wong, et al.
World Journal of Gastroenterology
|
September 26, 2022
Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma
Juliane Malik, Martin Klammer, Vinzent Rolny, et al.
World Journal of Gastroenterology
|
December 12, 2003
Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment
Henry Lik-Yuen Chan, May-Ling Wong, Alex Yui Hui, et al.
Antiviral Therapy
|
July 22, 2006
Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B
Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Alex Yui Hui, et al.
Plos One
|
August 5, 2011
The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity
Man-Shan Li, Terrence Chi-Kong Lau, Sophie Ka-Ping Chan, et al.
Journal of Gastroenterology and Hepatology
|
February 2, 2019
Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapy
Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Ching-Kong Loo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 25, 2015
Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis
Hwai-I Yang, Tai-Chung Tseng, Jessica Liu, et al.
Page
of 26
Search research articles
Search
Showing results (81-90 of 260) with videos related to
Sort By:
Page
of 26
The American Journal of Gastroenterology
|
May 17, 2002
Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection
Henry Lik-Yuen Chan, Steven Woon-Choi Tsang, Nancy Wai-Yee Leung, et al.
Journal of Cellular Biochemistry
|
October 21, 2005
Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis
Wai-Yip Lam, Kam-Tong Leung, Patrick Tik-Wan Law, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
September 24, 2004
Effect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of LI90, a human hepatic stellate cell line
Alex Yui Hui, Alfred Sze-Lok Cheng, Henry Lik-Yuen Chan, et al.
Journal of Gastroenterology and Hepatology
|
February 8, 2020
Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B
Terry Cheuk-Fung Yip, Hye Won Lee, Vincent Wai-Sun Wong, et al.
World Journal of Gastroenterology
|
September 26, 2022
Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma
Juliane Malik, Martin Klammer, Vinzent Rolny, et al.
World Journal of Gastroenterology
|
December 12, 2003
Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment
Henry Lik-Yuen Chan, May-Ling Wong, Alex Yui Hui, et al.
Antiviral Therapy
|
July 22, 2006
Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B
Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Alex Yui Hui, et al.
Plos One
|
August 5, 2011
The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity
Man-Shan Li, Terrence Chi-Kong Lau, Sophie Ka-Ping Chan, et al.
Journal of Gastroenterology and Hepatology
|
February 2, 2019
Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapy
Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Ching-Kong Loo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 25, 2015
Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis
Hwai-I Yang, Tai-Chung Tseng, Jessica Liu, et al.
Page
of 26